Prabha Sridevan, the former chairperson of India’s Intellectual Property Appellate Board, says that just as Indian companies must obey American laws when selling their wares in the US, international pharmaceutical companies must similarly comply with Indian laws if they wish to do business in the world’s second most populous market
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Leaders at US law firms explain what attorneys can learn from AI cases involving Meta and Anthropic, and why the outcomes could guide litigation strategies
A UDRP decision that found in favour of a small business in a domain name dispute could encourage more businesses to take a stand in ‘David v Goliath’ cases